146 related articles for article (PubMed ID: 37100501)
1. Systematic review and meta-analysis of prediction models used in cervical cancer.
Jha AK; Mithun S; Sherkhane UB; Jaiswar V; Osong B; Purandare N; Kannan S; Prabhash K; Gupta S; Vanneste B; Rangarajan V; Dekker A; Wee L
Artif Intell Med; 2023 May; 139():102549. PubMed ID: 37100501
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling.
Meads C; Auguste P; Davenport C; Małysiak S; Sundar S; Kowalska M; Zapalska A; Guest P; Thangaratinam S; Martin-Hirsch P; Borowiack E; Barton P; Roberts T; Khan K
Health Technol Assess; 2013 Mar; 17(12):1-323. PubMed ID: 23537558
[TBL] [Abstract][Full Text] [Related]
5. Prediction of local relapse and distant metastasis in patients with definitive chemoradiotherapy-treated cervical cancer by deep learning from [
Shen WC; Chen SW; Wu KC; Hsieh TC; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Yen KY; Kao CH
Eur Radiol; 2019 Dec; 29(12):6741-6749. PubMed ID: 31134366
[TBL] [Abstract][Full Text] [Related]
6. Effect of cervical cancer education and provider recommendation for screening on screening rates: A systematic review and meta-analysis.
Musa J; Achenbach CJ; O'Dwyer LC; Evans CT; McHugh M; Hou L; Simon MA; Murphy RL; Jordan N
PLoS One; 2017; 12(9):e0183924. PubMed ID: 28873092
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
8. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
Kokka F; Bryant A; Brockbank E; Powell M; Oram D
Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
[TBL] [Abstract][Full Text] [Related]
9. The effect of consolidation chemotherapy after concurrent chemoradiation on the prognosis of locally advanced cervical cancer: a systematic review and meta-analysis.
Zhong L; Li K; Song L; Yin R
J Obstet Gynaecol; 2022 Jul; 42(5):830-837. PubMed ID: 35148230
[TBL] [Abstract][Full Text] [Related]
10. Prediction of lymphovascular space invasion using a combination of tenascin-C, cox-2, and PET/CT radiomics in patients with early-stage cervical squamous cell carcinoma.
Li X; Xu C; Yu Y; Guo Y; Sun H
BMC Cancer; 2021 Jul; 21(1):866. PubMed ID: 34320931
[TBL] [Abstract][Full Text] [Related]
11. An MRI-based radiomics signature and clinical characteristics for survival prediction in early-stage cervical cancer.
Zheng RR; Cai MT; Lan L; Huang XW; Yang YJ; Powell M; Lin F
Br J Radiol; 2022 Jan; 95(1129):20210838. PubMed ID: 34797703
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive prediction of lymph node status for patients with early-stage cervical cancer based on radiomics features from ultrasound images.
Jin X; Ai Y; Zhang J; Zhu H; Jin J; Teng Y; Chen B; Xie C
Eur Radiol; 2020 Jul; 30(7):4117-4124. PubMed ID: 32078013
[TBL] [Abstract][Full Text] [Related]
13. External validation of a combined PET and MRI radiomics model for prediction of recurrence in cervical cancer patients treated with chemoradiotherapy.
Lucia F; Visvikis D; Vallières M; Desseroit MC; Miranda O; Robin P; Bonaffini PA; Alfieri J; Masson I; Mervoyer A; Reinhold C; Pradier O; Hatt M; Schick U
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):864-877. PubMed ID: 30535746
[TBL] [Abstract][Full Text] [Related]
14. Multiparametric magnetic resonance imaging-derived radiomics for the prediction of disease-free survival in early-stage squamous cervical cancer.
Zhou Y; Gu HL; Zhang XL; Tian ZF; Xu XQ; Tang WW
Eur Radiol; 2022 Apr; 32(4):2540-2551. PubMed ID: 34642807
[TBL] [Abstract][Full Text] [Related]
15. Association of MRI-derived radiomic biomarker with disease-free survival in patients with early-stage cervical cancer.
Fang J; Zhang B; Wang S; Jin Y; Wang F; Ding Y; Chen Q; Chen L; Li Y; Li M; Chen Z; Liu L; Liu Z; Tian J; Zhang S
Theranostics; 2020; 10(5):2284-2292. PubMed ID: 32089742
[TBL] [Abstract][Full Text] [Related]
16. Cervical cancer survival prediction by machine learning algorithms: a systematic review.
Rahimi M; Akbari A; Asadi F; Emami H
BMC Cancer; 2023 Apr; 23(1):341. PubMed ID: 37055741
[TBL] [Abstract][Full Text] [Related]
17. Delta-radiomics-based models for toxicity prediction in radiotherapy: A systematic review and meta-analysis.
Tan D; Mohamad Salleh SA; Manan HA; Yahya N
J Med Imaging Radiat Oncol; 2023 Aug; 67(5):564-579. PubMed ID: 37309680
[TBL] [Abstract][Full Text] [Related]
18. Survival outcome prediction in cervical cancer: Cox models vs deep-learning model.
Matsuo K; Purushotham S; Jiang B; Mandelbaum RS; Takiuchi T; Liu Y; Roman LD
Am J Obstet Gynecol; 2019 Apr; 220(4):381.e1-381.e14. PubMed ID: 30582927
[TBL] [Abstract][Full Text] [Related]
19. MRI-based radiomics value for predicting the survival of patients with locally advanced cervical squamous cell cancer treated with concurrent chemoradiotherapy.
Zhang X; Zhao J; Zhang Q; Wang S; Zhang J; An J; Xie L; Yu X; Zhao X
Cancer Imaging; 2022 Jul; 22(1):35. PubMed ID: 35842679
[TBL] [Abstract][Full Text] [Related]
20. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.
Liu R; Wang X; Tian JH; Yang K; Wang J; Jiang L; Hao XY
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD007563. PubMed ID: 25300170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
